Vascular Remodelling in Well-controlled Hypertensive Patients: The Challenge of Residual Risk Management

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|23|10|1445-1452

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.10, 2017-05, pp. : 1445-1452

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insomnia treatment: well-controlled clinical trials needed

By  

Inpharma, Vol. 1, Iss. 1428, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Effectiveness and Safety of Amlodipine in Newly Diagnosed Hypertensive Patients and in Previously Diagnosed Hypertensive Patients not Controlled with their Usual Treatment (NOTA Study)

By Valcárcel Y.  

Clinical Drug Investigation, Vol. 23, Iss. 12, 2003-01 ,pp. : 761-770

Adis International

Access to resources Recommend Favorite

Cardiovascular Risk in Obese Hypertensive Patients Taking Various Antihypertensive Drugs

By Schindler Christoph  

Clinical Drug Investigation, Vol. 27, Iss. 10, 2007-01 ,pp. : 707-717

Adis International

Access to resources Recommend Favorite

Aggressive treatment is essential to reduce cardiovascular risk in diabetic hypertensive patients

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 1, 2010-01 ,pp. : 8-11

Adis International

Access to resources Recommend Favorite

Statins may reduce CHD risk in non-dyslipidaemic hypertensive patients

By  

Inpharma, Vol. 1, Iss. 1382, 2003-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite